OMICS Group invites all the participants across the globe to attend the 4th World Congress on Bioavailability and Bioequivalence: Pharmaceutical R&D Summit during May 20-22, 2013 at DoubleTree by Hilton Beijing, China.
BABE-2013 is a scientific platform to meet fellow key decision makers all-around the Academic Institutions, Healthcare Institutes, Pharmaceutical, Biotech, CROs supply chain, Logistics practitioners making the congress a perfect platform to share experience, foster collaborations through the research talks & presentations to put forward many thought provoking strategies in Bioequivalence and Bioavailability, making the congress a perfect platform to share proficiency.
This conference has provided a forum for students, postdocs and established scientists to meet, exchange their ideas and enjoy the scientific as well as social interactions. It will also provide good insight in current thinking as to the design and analysis of Bioavailability and Bioequivalence studies of highly variable drugs and drug products, as viewed by pharmaceutical industry, academia and regulators.
The previous three conferences on BABE which were held at Hyderabad, India and Las Vegas, USA have explained how to analyze novel approaches in Bioavailability and Bioequivalence and have gained so much of interest for eminent scientists all over the world in Pharmaceutical R&D. Now it is the time for the 4th World Congress on Bioavailability and Bioequivalence: Pharmaceutical R&D Summit to share the knowledge and novel approaches in Bioavailability and Bioequivalence studies.